ChenMed Names Steve Nelson CEO, Chris Chen Executive Board Chair
New Roles Correspond with Company's Plan to Accelerate Growth, Serve More Seniors
Effective
ChenMed presently operates more than 130 senior medical centers in 15 states throughout the country and remains dedicated to the founding principle that underserved seniors deserve access to exemplary primary care to keep them healthy and out of the hospital. These leadership changes will build upon the company's success in serving individuals who have historically lacked access to coordinated health care, as it expands its presence to seniors in more areas of the country who can benefit from the preventive care model that ChenMed provides.
"My father's vision for the company and our family's commitment to bring our model of health care to those who need it most is now enabling hundreds of thousands of people to live healthier, more secure lives," said
"Having spent more than thirty years in health care, my time within this company this past year has enabled me to witness what true value-based care looks like, and how it can improve peoples' lives and transform healthcare in this nation," said
"I am confident that the combination of strengths within the partnership between Steve and me can accelerate growth to provide unprecedented access to patients around the country who deserve quality, affordable and coordinated care," said
About ChenMed
ChenMed, headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/chenmed-names-steve-nelson-ceo-chris-chen-executive-board-chair-302041321.html
SOURCE ChenMed
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meet the AI Future: Fifth GDTE to Be Held in Hangzhou, Zhejiang
- Apeing Enters Stage 5 of Presale as Community-Focused Ethereum Token Surpasses $106,000 Raised
- 2026 Chinese Opera Gala Opens in Kunshan, A Grand and Impressive Start
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share